
Syneos Health SYNH
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Syneos Health Zahlungsmittel 2011-2026 | SYNH
Zahlungsmittel Jährlich Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 M | 106 M | 272 M | 164 M | 154 M | 321 M | 102 M | 85 M | 126 M | 97 M | 81.4 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 321 M | 81.4 M | 147 M |
Zahlungsmittel Vierteljährlich Syneos Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.3 M | 111 M | 112 M | 170 M | 106 M | 119 M | 106 M | 123 M | 261 M | 265 M | 272 M | 249 M | 343 M | 336 M | 164 M | 129 M | 107 M | 108 M | 154 M | 132 M | 172 M | 187 M | 321 M | 304 M | 170 M | 164 M | 102 M | 103 M | 91.9 M | 53.2 M | 85 M | 136 M | 98.5 M | 156 M | 126 M | 126 M | 126 M | 126 M | 97 M | - | - | - | 81.4 M | - | - | - | 71 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 343 M | 53.2 M | 155 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
420 M | $ 203.25 | -0.63 % | $ 22.6 B | ||
|
Celcuity
CELC
|
166 M | $ 89.53 | -3.31 % | $ 4.19 B | ||
|
Fulgent Genetics
FLGT
|
50.2 M | $ 19.01 | 2.73 % | $ 585 M | ||
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
11.9 M | $ 4.37 | -2.93 % | $ 5.81 M | ||
|
Castle Biosciences
CSTL
|
117 M | $ 21.14 | 0.28 % | $ 613 M | ||
|
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
378 M | $ 129.99 | -0.1 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
65.4 M | $ 23.41 | 2.9 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
647 M | $ 146.03 | -3.81 % | $ 11.5 B | ||
|
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
1.42 B | $ 162.96 | 1.83 % | $ 25.3 B | ||
|
Interpace Biosciences
IDXG
|
2.5 M | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
359 M | $ 101.14 | 1.16 % | $ 6.83 B | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 186.89 | -1.56 % | $ 9.26 B | ||
|
Medpace Holdings
MEDP
|
497 M | $ 467.37 | 0.12 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
66.9 M | $ 1 131.06 | -2.74 % | $ 23.3 B | ||
|
NeoGenomics
NEO
|
160 M | $ 11.36 | -0.74 % | $ 1.46 B | ||
|
Myriad Genetics
MYGN
|
150 M | $ 4.49 | -1.21 % | $ 416 M | ||
|
National Research Corporation
NRC
|
4.14 M | $ 21.44 | 8.56 % | $ 480 M | ||
|
Natera
NTRA
|
1.08 B | $ 215.94 | -3.09 % | $ 29.5 B | ||
|
Pacific Biosciences of California
PACB
|
63.7 M | $ 1.39 | 1.46 % | $ 417 M | ||
|
Personalis
PSNL
|
124 M | $ 9.71 | -0.46 % | $ 867 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.65 | -3.21 % | $ 24.3 B | ||
|
Senseonics Holdings
SENS
|
40.2 M | $ 7.26 | -2.36 % | $ 303 M | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
2.4 M | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
183 M | $ 68.04 | -2.88 % | $ 4.07 B | ||
|
Laboratory Corporation of America Holdings
LH
|
532 M | $ 267.99 | -1.18 % | $ 22.3 B | ||
|
Thermo Fisher Scientific
TMO
|
9.85 B | $ 482.54 | -2.33 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.68 | 2.39 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
129 M | $ 9.24 | -0.59 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M |